A two phase study was performed to identify factors that influence the healing rate of duodenal ulcer. The study included an initial clinical trial in 145 patients and a second trial in a further 61 patients. AU patients were prescribed cimetidine at a daily dose of 800 mg for six weeks. The factors examined were age, sex, inpatient or outpatient treatment, duration of present ulcer pain, past history of duodenal ulcer, smoking, drinking, the length of time it took for symptoms to resolve after beginning treatment, and the characteristics of the ulcers themselves.
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Eighty four per cent of the duodenal ulcers healed after six weeks. Using univariate and multivariate analyses, it was found that three factors indicated a significant delaying effect on healing: (1) symptoms that persisted two weeks after treatment had begun; (2) heavy smoking (20 or more cigarettes daily); and (3) severe narrowing of the duodenal bulb. Patients with none of the three unfavourable factors (n=90) had a healing rate of 95 6% compared with patients with one (n=45) or two or more (n=10) factors, whose healing rates were 75*6% and 20-0% respectively (p<0.001). The corresponding figures in a second study were 88-9%, 55*0%, and 0%, respectively (p<0.001). A prognostic score based on these three factors represents the severity of duodenal ulcers with regard to healing in patients treated with cimetidine.
Although there have been a number of studies of the effect of drugs on duodenal ulcers, there are fewer reports on the effects of other factors on duodenal ulcer healing. This is because of the small number of patients studied, which has been enough to allow drug assessment Ulcers whose base seemed to be almost level with the surrounding mucosa were classified as 'flat', those with a clearly depressed base more than 4 mm from the margin were 'deep', and ulcers whose extent was between these two were described as 'moderate'. The degree of deformity of the duodenal bulb was scored4: 3= narrowing of the entrance or exit of the duodenal bulb by scarring, but still admitting the endoscope (external diameter=9 mm); 2=bilateral deformity; 1=unilateral deformity of bulb; 0= no deformity. All endoscopic findings were registered immediately after each endoscopy. The endoscopists were not aware of the clinical progress of the patients.
The patients recorded information on drug ingestion. The duration of the present ulcer pain was dated from the start of the present ulcer-like symptoms. Each patient was questioned about their ulcer symptoms every two weeks to determine when they had resolved.
The following characteristics were compared in patients whose ulcers healed within six weeks and 85 7%, respectively (p=0. 1303).
The degree of compliance with treatment was equally high in both healed and non-healed ulcer groups. Both groups showed a compliance of more than 90% during the entire period of the study.
Among the endoscopic findings, the degree of deformity of the duodenal bulb was the only significant factor influencing the healing rate (Table III ). An ulcer associated with severe narrowing was significantly slower to heal. The numbers of ulcers, their shape, size, depth, site, and the stage of duodenal ulcers had no effect on the healing. Table IV shows the results of multiple linear regression analysis. The following three factors were significant in delayed healing: symptoms that did not resolve within two weeks of beginning treatment (p<001); smoking more than 20 cigarettes per day during treatment (p<0 01); severe narrowing of duodenal bulb (p<0 01). When these factors were taken into account other factors were not significant.
The prognostic scoring system was one in which each unfavourable factor was given equal weight. The patients with varying numbers of a total of three unfavourable factors were classified into four groups (Table V) . With increases in the prognostic score, the healing rate decreased from 95-6% (score of 0) to 75-6% (score of 1) to 20-0% (score of 2 and 3) (p<0 001). PHASE Patient compliance with drug treatment is very important in evaluating the failure of duodenal ulcers to heal.2324 There'was no difference in compliance between the healed and nonhealed ulcer groups in this study so we did not consider compliance as a factor to be considered.
It is noteworthy that ulcer healing was delayed in patients whose symptoms persisted two weeks after the start of treatment with cimetidine. Massarrat et al'6 also reported that pain duration during treatment was significantly longer in their unhealed group than in the healed group in patients with duodenal ulcers being treated with antacids. Ippoliti et al,25 however, reported that there was no correlation between the pain duration and ulcer healing. Similarly, in a study26 we found that if symptoms persisted one week after the start of treatment with cimetidine gastric ulcer healing would be delayed. What this means is not clear at present but it is possible that this finding is associated with acid hypersecretion.
Smoking has been found to delay the healing of duodenal ulcer in various treatment regimens such as placebo,'27 trimipramine, 28 
